Equity
€1.4m ▲ 19.3%
Lodewick has made a profit in every financial year since 2019.
Lodewick
Lifetime
7 annual accounts with figures on one time axispeak €289,151 (2025)
€289,151▲ 46.5%
peak €226,731 (2025)
€226,731▲ 39.3%
peak €1.4m (2025)
€1.4m▲ 19.3%
€60,388▼ 77.4%
Board2 names since 2019
2 directors and 1 other
Documentsfilings and deeds
28-09-202659 days late
2025micro format
Gross margin from €197,328 to €289,151Result from €162,720 to €226,731Equity from €1.2m to €1.4mDebts from €267,372 to €60,388Cash from €47,408 to €341,239
Key points
from the 2025 annual accountsResult
€226,731 ▲ 39.3%
The result rose in 2025 from €162,720 to €226,731.
Turnover
≈ €440,000 estimated
The micro format states no turnover.
Liquidity
24.33 was 5.13 in 2024
Short-term debts fell from €263,056 to €56,862.
Filings
7 annual accounts 4 late
The 2019 accounts came latest: 111 days after the end of the period.
Position in the sector
€1.4m
More equity than 95% of companies in human health. Sector median €125,064 · 21,313 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,780 companies had the same profile as Lodewick has now. Each dot stands for 17 companies, two years later.
96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,780 companies, not a prediction for Lodewick. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 27-11-2019
Director, since 13-03-2026
- all the sharesdeed of 02-12-2019
Recent changes
Appointment: (director)
General meeting of 13-03-2026 · Gazette deed
Registered office moved from Destelbergen to Heusden
New registered office: Reukenwegel 15, 9070 Heusden · Previous registered office: Ellebogten 22, 9070 Destelbergen · Board meeting of 02-02-2026 · Gazette deed
Incorporation
Registered office moved to Destelbergen · New registered office: Ellebogten 22, 9070 Destelbergen · Previous registered office: Terneuzen (Nederland) · published on 02-12-2019 · Gazette deed
First establishment
Reukenwegel 15, Destelbergen
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Lodewick Destelbergen | €1.5m | €289,151 | 95.9% | - |
| DR. MARGOT CLAUS Sint-Martens-Latem | €1.4m | €324,346 | 20.2% | - |
| Docteur Bachir Harkat Mons | €1.4m | €274,727 | 34.8% | - |
| Oogarts Deborah De Bruyn Lebbeke | €1.2m | €327,912 | 8.5% | - |
| Dr. Deleu, Medisch Oncoloog Waasmunster | €1.4m | €312,144 | 85.6% | - |
| Dr. C. Naeyaert Hamme (Vl.) | €1.2m | €254,271 | 34.1% | - |
| Tom Maertens, anesthesist Wortegem-Petegem | €1.5m | €367,166 | 25.5% | - |
These companies have the same main activity as Lodewick: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.2m and €1.5m, founded between 2017 and 2020.
Official details
Source: KBO- Status
- Active since 28-11-2019Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.296.383.9389070 Destelbergen, since 28-11-2019
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on Lodewick
Lodewick files the micro format. That format states no turnover. The gross margin rose from €131,753 in 2019 to €289,151 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Lodewick
- What is the company number of Lodewick?
- The company number of Lodewick is 0738.537.610. The VAT number is the same number with BE in front: BE 0738.537.610.
- Where is Lodewick based?
- The registered office is at Reukenwegel 15, 9070 Destelbergen.Company details
- What does Lodewick do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of Lodewick?
- Lodewick is a private limited company (BV).
- When was Lodewick founded?
- Lodewick was founded on 28-11-2019.
- Is Lodewick still active?
- Yes, Lodewick is an active enterprise in the KBO register.
- What is the turnover of Lodewick?
- The turnover in financial year 2025 is ≈ €440,000. This figure is estimated from the gross margin of €289,151 and 30 comparable companies (NACE 86220). It probably lies between €390,000 and €610,000.Financials
- Is Lodewick profitable?
- In financial year 2025, Lodewick made a profit of €226,731.
- Where can I find the annual accounts of Lodewick?
- Lodewick filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Lodewick due?
- Lodewick must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.